Building the Business Case for Digital Endpoints

How do we unlock the true potential of digital endpoints in clinical trials?

Digital measures not only provide the clinical trials community with unprecedented insights into people’s true lived experiences, but they advance our comprehension of so many indications. Our recent findings, in partnership with Tufts Center for the Study of Drug Development and other industry leaders, showcase evidence of significant cost reductions and financial benefits tied to leveraging digital endpoints in trials. Why, then, have we not deployed digital endpoints at scale?

Join our next DATAcc by DiMe project as we lay the foundation for the transformation of the clinical trials enterprise by developing a value framework, industry benchmarking tools, forecasting models, and a modular template business case framework to support innovators across the field to invest in digital endpoints and advance their broad adoption and scale in clinical research.

Become a part of the DATAcc by DiMe community and share your interest in being a part of this project today.